Incannex Healthcare Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-46.9M | $-18.5M | $-48.8M | $-14.9M | $-11.4M | $-4.7M |
| Depreciation & Amortization | $246.0K | $103.0K | $88.0K | — | — | — |
| Depreciation | $143.00B | $103.00B | $23.0M | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $2.6M | $8.9M | $2.1M | $1.5M | $600.0K | $565.4K |
| Net Cash from Operating Activities | $-12.5M | $-15.8M | $-10.7M | $-12.8M | $-6.9M | $-3.9M |
| Investing Activities | ||||||
| Capital Expenditures | $8.0K | $277.0K | $316.0K | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-8.0K | $-277.0K | $-316.0K | — | $29.3K | $13.0K |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $21.4M | — | $8.2M | $41.2M | $12.4M | $7.4M |
| Net Change in Cash | — | — | — | $28.4M | $5.5M | $3.5M |
| Free Cash Flow | $-12.5M | $-16.1M | $-11.1M | — | — | — |